Bal Pharma Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2025, 1. Approved the audited financial results ( stand alone and consolidated )of the Company for the financial year ended 31.03.20252.Recommended Final Dividend of Re.1.2 per equity share of Rs.10 each , subject to the approval of members at the ensuing AGM